Myocardial Infarction

Men with hypogonadism and heart disease or risk factors saw no increased risk vs placebo

Health news and commentary from around the Web gathered by MedPage Today staff

Health news and commentary from around the Web gathered by MedPage Today staff

Study outlines room for improvement

Early results promising with DynamX bioadaptor, though traditional BRS hasn't been abandoned

Also in TTHealthWatch: beta-blockers after myocardial infarction

Do they still have a role for people without heart failure or LV systolic dysfunction?

Different thresholds for myocardial injury suggested for pediatric patients

Natural history study lays the groundwork for intervention trials

Also in TTHealthWatch: low-risk prostate cancer in the U.S.

Sex disparities in adverse outcomes, including death, didn't change in the last decade

Report of ESC 0/1-hour hs-cTnT algorithm's diagnostic performance goes against the grain

Health news and commentary from around the Web gathered by MedPage Today staff

Surgeons fire back at downgrading of CABG in recent guidelines